- $172.35m
- $167.26m
- $109.43m
OptimizeRx Corp reports results for the quarter ended March 31 - Earnings Summary
OptimizeRx Corp expected to post a loss of 12 cents a share - Earnings Preview
Brief: OptimizeRx Corp Files For Mixed Shelf Of Up To $75 Million - SEC Filing
OptimizeRx Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: OptimizeRx fourth-quarter results beat estimates
Brief: OPTIMIZERx receives director nominations from Whetstone Capital Advisors
OptimizeRx Corp expected to post earnings of 27 cents a share - Earnings Preview
Brief: OPTIMIZERx appoints Stephen Silvestro as CEO
U.S. RESEARCH ROUNDUP-Cisco, Freshpet, Nvidia
OptimizeRx Corp reports results for the quarter ended September 30 - Earnings Summary
OptimizeRx Corp expected to post earnings of 6 cents a share - Earnings Preview
OptimizeRx Corp expected to post earnings of 6 cents a share - Earnings Preview
Brief: OptimizeRx Continues To Expand Its Strategic Relationship With Top-Tier Pharma Client
U.S. RESEARCH ROUNDUP- Advance Auto Parts, Molina Healthcare, Walmart
OptimizeRx Corp reports results for the quarter ended in June - Earnings Summary
OptimizeRx Corp expected to post a loss of 6 cents a share - Earnings Preview
Optimizerx Corp Expected To Post A Loss Of 13 Cents A Share: Earnings Preview
Brief: Optimizerx Corp- On March 29 Entered Into Amendment No. 1 To Financing Agreement Dated Oct. 11, 2023
Brief: OptimizeRx Corp Files For Non Timely Annual Report